4//SEC Filing
Schuetz Thomas J. 4
Accession 0001171843-25-003462
CIK 0001738021other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 3:24 PM ET
Size
5.9 KB
Accession
0001171843-25-003462
Insider Transaction Report
Form 4
Schuetz Thomas J.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Purchase
Common Stock
2025-05-27$2.11/sh+10,000$21,100→ 6,480,825 total
Footnotes (2)
- [F1]The price reported in Column 4 is the weighted average purchase price. These shares were purchased in two transactions at prices of $2.105 and $2.115 per share. The reporting person hereby undertakes to provide, upon request, to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, full information regarding the number of shares purchased and prices within the range set forth above.
- [F2]150,000 of the shares represent unvested RSUs granted on November 16, 2021. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on November 15, 2022. 250,000 of the shares represent unvested RSUs granted on February 8, 2023. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on February 8, 2024. 478,125 of the shares represent unvested RSUs granted on January 9, 2024. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 9, 2025.
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0001591464
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 3:24 PM ET
- Size
- 5.9 KB